ArticleSkin health and disease2026
Trial of novel image-enhancement software to assist medical students in identifying dermoscopic features of melanoma.
Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early detection of melanoma is central to reducing the disease-related burden. The dermatoscope is used by skin cancer clinicians to help identify features of melanoma in a skin lesion. Features can be subtle and identification can be a challenge for early dermoscopists. Objectives: To investigate the utility of novel image-enhancement software as a possible aid for beginner dermoscopists in identifying melanoma features. The software had previously been developed for optometry for the diagnosis and monitoring of anterior eye conditions. Methods: Following an introductory lecture on dermoscopy, third-year medical students at James Cook University were asked to complete a 10-lesion test set of dermoscopic images on benign lesions and cutaneous melanoma (CM). Students scored the presence or absence of some melanoma-related features (asymmetry, blue-grey colour, atypical network) and made a diagnosis for a standard image and then for the matching enhanced image. Results: In total, 61 students participated. Total performance scores did not differ significantly between standard and enhanced images of the benign lesions. However, students correctly identified CM-related features (blue-grey colour Conclusions: The image-enhancement software shows promise in assisting beginner dermoscopists in identifying some features of melanoma and could be tested with more advanced dermoscopists along with a wider range of dermoscopic features. The software could potentially be made widely and cheaply available in the form of a mobile phone application or be incorporated into an existing image-management platform.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.